Hailong Wu

机构：Shanghai University of Traditional Chinese Medicine, Peking University Shenzhen Hospital, Shanghai University of Medicine and Health Sciences · ORCID：0000-0003-3517-4230

发表论文 39 篇 · 总被引 1418 次 · h-index 19

代表论文

• The Role of Nrf2 in Liver Disease: Novel Molecular Mechanisms and Therapeutic Approaches (2019 · Frontiers in Pharmacology · 被引 263)
• Blocking GSDMD processing in innate immune cells but not in hepatocytes protects hepatic ischemia–reperfusion injury (2020 · Cell Death and Disease · 被引 105)
• Quercetin, a natural flavonoid, protects against hepatic ischemia–reperfusion injury via inhibiting Caspase-8/ASC dependent macrophage pyroptosis (2024 · Journal of Advanced Research · 被引 52)
• C‐C motif chemokine ligand 5 confines liver regeneration by down‐regulating reparative macrophage‐derived hepatocyte growth factor in a forkhead box O 3a–dependent manner (2022 · Hepatology · 被引 52)
• ID3 Promotes Stem Cell Features and Predicts Chemotherapeutic Response of Intrahepatic Cholangiocarcinoma (2018 · Hepatology · 被引 46)
• Efficacy of zero nitrous oxide emitting aerobic denitrifying bacterium, Methylobacterium gregans DC-1 in nitrate removal with strong auto-aggregation property (2019 · Bioresource Technology · 被引 43)